← FDA DRUG APPROVALS

FDA ANDA · ANDA080884

DELTALIN

Sponsor: LILLY

APPLICATION
ANDA080884
TYPE
ANDA
ORIGINAL APPROVAL
1973-06-12
LATEST ACTION
1991-01-15
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DELTALINDiscontinued
ERGOCALCIFEROL 50,000 IU · CAPSULE · ORAL

Approval history

1991-01-15Labeling · Supplement 10AP
1985-10-18Labeling · Supplement 9AP
1973-06-12OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →